Loading...

LCTX LINEAGE CELL THERAPEUTICS INC Investments/Divestments 8-K Filing

LNG

LCTX

LINEAGE CELL THERAPEUTICS INC

(LCTX)

2024 8-K

Show Summary

Show Summary

Product Expansion

Appointing New Auditor

Financial Statements

Product Expansion

Financial Results

Shareholder Approval

Securities Offering

Financial Results

Earnings Reports

Change of Auditor

Bylaws Amendment and Annual...

Earnings Reports

Sales Agreement

Earnings Reports

Announcement of Annual Meeting

Stock Purchase Agreement

Earnings Reports

Earnings Reports

Announcement of Annual Meeting

Opinion on Common Share Iss...

Earnings Reports

External Links:

Lineage Cell Therapeutics, Inc. filed a prospectus supplement for the offer and sale of common shares with an aggregate offering price of up to $39,966,424 through B. Riley Securities, Inc.

AI Assistant

LINEAGE CELL THERAPEUTICS INC

2024

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.